Two Hogan & Hartson Advisories on the Use of Social Media

Hogan & Hartson has just authored an advisory, available by clicking here, setting forth the considerations that arise when social media is used by three different groups — an entity itself, the employees of that entity, and third parties in reference to the entity. We discuss the benefits of social media, as well as issues and risks, from each of these three angles.

Also, the U.S. Food and Drug Administration recently announced that it will hold a two-day public hearing in November on how pharmaceutical companies use the web and social-media tools to market their products.  This is the first step in a process that will establish guidelines for drug makers using the tools of social networking.  The Hogan & Hartson advisory on this development is available by clicking here.

Authored by Christopher Wolf